Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-γ and IL-4

Immunology

Volumn 123, Issue 1, 2008, Pages 100-107

  Iizuka, Akira ^a,b,c   Ikarashi, Yoshinori ^a   Yoshida, Mitsuzi ^a   Heike, Yuji ^c   Takeda, Kazuyoshi ^d   Quinn, Gary ^a   Wakasugi, Hiro ^a   Kitagawa, Masanobu ^b   Takaue, Yoichi ^c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycolipid; Interferon ; Interleukin 4; Natural killer T cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; GROWTH RATE; IMMUNOREGULATION; IN VITRO STUDY; INBRED STRAIN; INTERFERON PRODUCTION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPERNATANT; TH2 CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY; TH2 CELLS;

EID: 37149019856     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02732.x     Document Type: Article

References (45)

1. + subset. J Immunol 1990 145 : 1039 45.
2. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000 21 : 573 83.
3. Makino Y, Koseki H, Adachi Y, Akasaka T, Tsuchida K, Taniguchi M. Extrathymic differentiation of a T cell bearing invariant Vα14 Jα281 TCR. Int Rev Immunol 1994 11 : 31 46.
4. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2001 2 : 971 8.
5. Mattner J, Debord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005 434 : 525 9.
6. - T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. J Immunol 1997 158 : 5698 706.
7. van Der Vliet HJ, Nishi N, de Gruijl TD, von Blomberg BM, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000 95 : 2440 2.
8. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 114 : 1379 88.
9. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994 180 : 423 32.
10. +Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells. Blood 2001 97 : 2067 74.
11. + natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Immunology 2000 99 : 229 34.
12. + NKT cell-mediated cytotoxicity. Int J Cancer 2006 119 : 630 7.
13. Smyth MJ, Thia KY, Street SE et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000 191 : 661 8.
14. Seino K, Motohashi S, Fujisawa T, Nakayama T, Taniguchi M. Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 2006 97 : 807 12.
15. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 2001 167 : 3114 22.
16. Giaccone G, Punt CJ, Ando Y et al. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002 8 : 3702 9.
17. Shimizu K, Hidaka M, Kadowaki N et al. Evaluation of the function of human invariant NKT cells from cancer patients using alpha-galactosylceramide- loaded murine dendritic cells. J Immunol 2006 177 : 3484 92.
18. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, Wang CR, Joyce S, Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 2005 115 : 2572 83.
19. Ishikawa A, Motohashi S, Ishikawa E et al. A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2005 11 : 1910 7.
20. + natural killer T cells of healthy volunteers and cancer patients using α-galactosylceramide-loaded and environmentally instructed dendritic cells. Cancer Res 2003 63 : 4101 6.
21. + NKT cells cultured in the absence of animal materials. J Immunother 2005 28 : 314 21.
22. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001 193 : 1221 6.
23. - invariant Vα14 natural killer T (Vα14i NKT) cells using α- galactosylceramide and IL-2. Immunol Lett 2005 101 : 160 7.
24. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000 192 : 741 54.
25. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 2002 99 : 1259 66.
26. + T cells provide an early source of IFN-γ. J Immunol 2003 170 : 2399 408.
27. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998 9 : 345 53.
28. - strains. Exp Anim 2000 49 : 171 80.
29. Beutner U, Launois P, Ohteki T, Louis JA, MacDonald HR. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production. Eur J Immunol 1997 27 : 928 34.
30. + T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following α-galactosylceramide stimulation. Cancer Sci 2003 94 : 383 8.
31. + NKT cells derived from G-CSF-mobilized blood cells. J Immunother 2006 29 : 320 7.
32. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998 188 : 1521 8.
33. + T cells in vitro. Hum Immunol 2000 60 : 357 65.
34. van der Vliet HJ, Nishi N, Koezuka Y et al. Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Meth 2001 247 : 61 72.
35. + T cells. J Immunol 1999 162 : 7067 74.
36. Zhu R, Diem S, Araujo LM et al. The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 2007 178 : 5435 42.
37. Bezbradica JS, Stanic AK, Matsuki N et al. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol 2005 174 : 4696 705.
38. Minami K, Yanagawa Y, Iwabuchi K, Shinohara N, Harabayashi T, Nonomura K, Onoe K. Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions. Blood 2005 106 : 1685 93.
39. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002 296 : 553 5.
40. + CD1d-dependent precursor stage. J Exp Med 2002 195 : 835 44.
41. Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2001 2 : 917 24.
42. + T cells in a manner dependent on IL-4. Int Immunol 2006 18 : 1397 404.
43. Morris SC, Orekhova T, Meadows MJ, Heidorn SM, Yang J, Finkelman FD. IL-4 induces in vivo production of IFN-γ by NK and NKT cells. J Immunol 2006 176 : 5299 305.
44. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA, Gapin L, Glimcher LH. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 2004 20 : 477 94.
45. Matsuda JL, Zhang Q, Ndonye R, Richardson SK, Howell AR, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Vα14i NKT cells. Blood 2006 107 : 2797 805.